loadpatents
name:-0.020840883255005
name:-0.0087080001831055
name:-0.0015389919281006
Dariani; Maghsoud M. Patent Filings

Dariani; Maghsoud M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dariani; Maghsoud M..The latest application filed is for "method of treating attention deficit disorders with d-threo methylphenidate".

Company Profile
0.8.18
  • Dariani; Maghsoud M. - Fanwood NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method Of Treating Attention Deficit Disorders With D-threo Methylphenidate
App 20130109719 - Zeitlin; Andrew L. ;   et al.
2013-05-02
Methods For Treatment Of Cognitive And Menopausal Disorders With D-threo Methylphenidate
App 20130053414 - Zeldis; Jerome B. ;   et al.
2013-02-28
Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
App 20110257227 - ZELDIS; Jerome B. ;   et al.
2011-10-20
Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
App 20110201645 - Zeitlin; Andrew L. ;   et al.
2011-08-18
Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
App 20100093797 - Zeldis; Jerome B. ;   et al.
2010-04-15
Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
App 20100035928 - Zeitlin; Andrew L. ;   et al.
2010-02-11
Chronic, Bolus Adminstration Of D-Threo Methylphenidate
App 20090088455 - Dariani; Maghsoud M. ;   et al.
2009-04-02
Delivery of multiple doses of medications
Grant 7,431,944 - Mehta , et al. October 7, 2
2008-10-07
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
Grant 7,115,631 - Zeldis , et al. October 3, 2
2006-10-03
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
App 20060183774 - Zeldis; Jerome B. ;   et al.
2006-08-17
Method of treating attention deficit disorders with d-threo methylphenidate
App 20060030587 - Zeitlin; Andrew L. ;   et al.
2006-02-09
Method of treating attention deficit disorders with D-threo methylphenidate
App 20050119307 - Zeitlin, Andrew L. ;   et al.
2005-06-02
Chronic, bolus administration of D-threo methylphenidate
App 20050049279 - Dariani, Maghsoud M. ;   et al.
2005-03-03
Delivery of multiple doses of medications
App 20040091532 - Mehta, Atul M. ;   et al.
2004-05-13
Chronic, bolus administration of D-threo methylphenidate
App 20030232857 - Dariani, Maghsoud M. ;   et al.
2003-12-18
Delivery of multiple doses of medications
Grant 6,635,284 - Mehta , et al. October 21, 2
2003-10-21
Chronic, bolus administration of D-threo methylphenidate
Grant 6,602,887 - Dariani , et al. August 5, 2
2003-08-05
Delivery Of Multiple Doses Of Medications
App 20030113373 - MEHTA, ATUL M. ;   et al.
2003-06-19
Phenidate drug formulations having diminished abuse potential
Grant 6,528,530 - Zeitlin , et al. March 4, 2
2003-03-04
Phenidate drug formulations having diminished abuse potential
App 20020035126 - Zeitlin, Andrew L. ;   et al.
2002-03-21
Phenidate drug formulations having diminished abuse potential
Grant 6,355,656 - Zeitlin , et al. March 12, 2
2002-03-12
Chronic, bolus administration of D-threo methylphenidate
App 20010041717 - Dariani, Maghsoud M. ;   et al.
2001-11-15
Chronic, bolus administration of D-threo methylphenidate
Grant 6,255,325 - Dariani , et al. July 3, 2
2001-07-03
Delivery of multiple doses of medications
Grant 5,837,284 - Mehta , et al. November 17, 1
1998-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed